CN Patent

CN102006864A — β-阻断剂在制备用于治疗血管瘤药物中的用途

Assigned to Universite de Bordeaux · Expires 2011-04-06 · 15y expired

What this patent protects

本发明涉及β-阻断剂在制备用于治疗血管瘤，例如婴儿血管瘤药物中的用途。所述β-阻断剂可以是非选择性的β-阻断剂，例如萘心安。本发明提供了一般用于治疗血管瘤的已知化合物，例如皮质类固醇、干扰素或长春新碱的替代药物。

USPTO Abstract

本发明涉及β-阻断剂在制备用于治疗血管瘤，例如婴儿血管瘤药物中的用途。所述β-阻断剂可以是非选择性的β-阻断剂，例如萘心安。本发明提供了一般用于治疗血管瘤的已知化合物，例如皮质类固醇、干扰素或长春新碱的替代药物。

Drugs covered by this patent

propranolol-hydrochloride (PROPRANOLOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN102006864A
Jurisdiction: CN
Classification: —
Expires: 2011-04-06
Drug substance claim: No
Drug product claim: No
Assignee: Universite de Bordeaux
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.